目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Epigenetics Drugs & Diagnostic Technologies Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Epigenetics Drugs & Diagnostic Technologies Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Epigenetics Drugs & Diagnostic Technologies Market: Product & Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Epigenetics Drugs & Diagnostic Technologies Market: Product & Service Movement Analysis, USD Million, 2023 & 2030
4.3. Diagnostics
4.3.1. Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Reagents
4.3.2.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Kits
4.3.3.1. Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.2. ChIP Sequencing Kit
4.3.3.2.1. ChIP Sequencing Kit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.3. Whole Genomic Amplification Kit
4.3.3.3.1. Whole Genomic Amplification Kit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.4. Bisulfite Conversion Kit
4.3.3.4.1. Bisulfite Conversion Kit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.5. RNA Sequencing Kit
4.3.3.5.1. RNA Sequencing Kit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.6. Others
4.3.3.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Instruments
4.3.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Enzymes
4.3.5.1. Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.6. Services
4.3.6.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Drugs
4.4.1. Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Histone Deacetylase (HDAC) Inhibitors
4.4.2.1. Histone Deacetylase (HDAC) Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. DNA Methyltransferase (DNMT) Inhibitors
4.4.3.1. DNA Methyltransferase (DNMT) Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Epigenetics Drugs & Diagnostic Technologies Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Epigenetics Drugs & Diagnostic Technologies Market: Application Movement Analysis, USD Million, 2023 & 2030
5.3. Oncology
5.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Solid Tumors
5.3.2.1. Solid Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Liquid Tumors
5.3.3.1. Liquid Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Non-oncology
5.4.1. Non-oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.1.1. Inflammatory Diseases
5.4.1.1.1. Inflammatory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.1.2. Metabolic Diseases
5.4.1.2.1. Metabolic Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.1.3. Infectious Diseases
5.4.1.3.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.1.4. Cardiovascular Diseases
5.4.1.4.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.1.5. Others
5.4.1.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Epigenetics Drugs & Diagnostic Technologies Market: Regional Estimates & Trend Analysis
6.1. Epigenetics Drugs & Diagnostic Technologies Market Share, By Region, 2023 & 2030, USD Million
6.2. North America
6.2.1. North America Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. China
6.4.2.1. China Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Japan Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. South Korea
6.4.5.1. South Korea Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Australia
6.4.6.1. Australia Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Epigenetics Drugs & Diagnostic Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Hoffmann-La Roche Ltd.
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Thermo Fisher Scientific Inc.
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Eisai Co., Ltd.
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Novartis AG
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. ELEMENT BIOSCIENCES
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Cantata Bio
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Illumina, Inc.
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Promega Corporation.
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Abcam Limited.
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. Merck KGaA
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives